A Prospective Randomized Trial to Compare Basal Bolus therapies that use either Insulin Lispro Protamine Suspension or Insulin Glargine together with Lispro Insulin in Patients with Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2013
At a glance
- Drugs Insulin glargine (Primary) ; Insulin lispro (Primary) ; Insulin neutral protamine lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms IOPJ
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 16 Sep 2011 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History